AER-271 is primarily investigated for its potential therapeutic applications in treating neurological disorders, particularly those involving oxidative stress and neuroinflammation. It is being studied for its efficacy in conditions such as Alzheimer's disease, where it may help mitigate neuronal damage by targeting specific pathways associated with inflammation and oxidative damage. Additionally, AER-271 shows promise in preclinical models for its neuroprotective properties, potentially aiding in the recovery and preservation of cognitive functions. Its application extends to research in stroke and traumatic brain injury, where it may reduce secondary injury mechanisms and improve outcomes. Ongoing studies aim to further elucidate its mechanisms and optimize its use in clinical settings.